Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emerin presence in platelets.

S Squarzoni1, P Sabatelli, C Capanni

  • 1Ist. Citomorfologia N.P. CNR, IOR, Bologna, Italy. squarzoni@area.bo.cnr.it

Acta Neuropathologica
|August 31, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients.

Scientific reports·2023
Same author

Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study.

Breast cancer research and treatment·2021
Same author

Targeted whole exome sequencing and Drosophila modelling to unveil the molecular basis of primary ovarian insufficiency.

Human reproduction (Oxford, England)·2021
Same author

Non-Compartment and compartmental pharmacokinetics, efficacy, and safety of Kedrion FIX concentrate.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2020
Same author

Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study.

Breast (Edinburgh, Scotland)·2019
Same author

High-resolution array-CGH analysis on 46,XX patients affected by early onset primary ovarian insufficiency discloses new genes involved in ovarian function.

Human reproduction (Oxford, England)·2019
Same journal

Mutation-specific neuropathologic signatures in MAPT-associated frontotemporal lobar degeneration.

Acta neuropathologica·2026
Same journal

Molecular changes during AT/RT progression associated with epithelial-mesenchymal transition and extracellular matrix changes.

Acta neuropathologica·2026
Same journal

Prion-like transmission and propagation of human β-amyloid to the bank vole rodent model.

Acta neuropathologica·2026
Same journal

Inhibition of tRNA fragments dysregulated in human mTLE exacerbates pathology and seizure activity.

Acta neuropathologica·2026
Same journal

VMA21 deficiency leads to autophagic dysregulation and altered vesicle trafficking in X-linked myopathy with excessive autophagy.

Acta neuropathologica·2026
Same journal

Donor-specific pathological features associate with genetic background, lesion type distribution, and clinical heterogeneity in multiple sclerosis.

Acta neuropathologica·2026
See all related articles

Emerin protein, abnormal in Emery-Dreifuss muscular dystrophy (EMD), is found in normal human platelets but absent in EMD patients. This confirms emerin

Area of Science:

  • Cell Biology
  • Molecular Medicine
  • Genetics

Background:

  • Emerin is a protein associated with X-linked Emery-Dreifuss muscular dystrophy (EMD), a condition causing muscle weakness, joint contractures, and cardiac arrhythmia.
  • Emerin is primarily localized at the nuclear rim, but its presence in the cytoplasm is debated.
  • The precise function of emerin remains largely unknown.

Purpose of the Study:

  • To investigate the localization of emerin in cellular components beyond the nucleus.
  • To determine if emerin is present in circulating blood cells, specifically platelets.
  • To correlate emerin presence/absence in platelets with X-linked Emery-Dreifuss muscular dystrophy (EMD).

Main Methods:

  • Analysis of emerin presence in circulating human platelets from normal individuals and EMD patients.

Related Experiment Videos

  • Examination of emerin localization within megakaryocytes and circulating granulocytes.

    • Main Results:

    • Emerin was detected in circulating platelets from healthy individuals.
    • Emerin was notably absent in platelets from patients with X-linked Emery-Dreifuss muscular dystrophy (EMD).
    • Emerin was identified in the cytoplasm of megakaryocytes but not in circulating granulocytes.

    Conclusions:

    • The presence of emerin in platelets, which are cytoplasmic fragments, confirms its cytoplasmic localization.
    • This cytoplasmic localization suggests potential roles for emerin beyond the nuclear envelope, possibly related to platelet function.
    • The absence of emerin in EMD patient platelets provides a potential diagnostic marker and further insight into the disease mechanism.